4.3 Article

Cardiomyopathy due to ingestion of Adderall

Journal

AMERICAN JOURNAL OF THERAPEUTICS
Volume 15, Issue 3, Pages 287-289

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MJT.0b013e3180ed6291

Keywords

Adderall; Ritalin; dextroamphetamine; amphetamine; cardiomyopathy

Ask authors/readers for more resources

A patient is described who developed cardiomyopathy after receiving a therapeutic course of dextroamphetamine/amphetamine. The patient's cardiac function deteriorated to the point of heart failure, necessitating a heart transplantation. Cardiomyopathy associated with amphetamine use is a serious and potentially lethal condition. With early diagnosis, identification of the cause, and treatment, cardiomyopathy may be reversible. The dangers of therapeutic use of amphetamines are discussed, as well as problems and assumptions associated with U.S. Food and Drug Administration monitoring and removal from the market of harmful substances.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available